<DOC>
	<DOCNO>NCT01809093</DOCNO>
	<brief_summary>You ask research study determine blood level vitreous level compound call thrombospondin 1 ( TSP1 ) pigment epithelium derive factor ( PEDF ) . These compound exist naturally body .</brief_summary>
	<brief_title>Thrombospondin-1 Pigmented Epithelium Derived Factor Levels Patients With Diabetes Mellitus .</brief_title>
	<detailed_description>The hypothesis test diabetic patient express high molecular weight pigment epithelium-derived factor ( PEDF ) isoform low thrombospondin-1 ( TSP1 ) level , result , great risk development severe diabetic retinopathy .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Pigment epithelium-derived factor</mesh_term>
	<criteria>Ability provide write informed consent comply study assessment full duration study Diabetes Mellitus Undergoing par plana vitrectomy reason Use antiVEGF ( vascular endothelial growth factor ) medication</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>PEDF</keyword>
	<keyword>TSP1</keyword>
	<keyword>Thrombospondin</keyword>
	<keyword>pigment epithelium derive factor</keyword>
	<keyword>Wills Eye Institute</keyword>
	<keyword>Pars plana vitrectomy</keyword>
	<keyword>Vitreous level</keyword>
	<keyword>Mid Atlantic Retina</keyword>
	<keyword>Blood draw</keyword>
	<keyword>Blood test</keyword>
</DOC>